Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
Holding FBLG?
Track your performance easily
FBLG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.08 - $55.00
Previous Close$3.16
Volume2.00M
Average Volume (3M)464.55K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$5.97M
Total Debt (Recent Filing)$1.84M
Price to Earnings (P/E)―
Beta-0.99
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding35,159,125
10 Day Avg. Volume1,346,035
30 Day Avg. Volume464,548
Standard Deviation0.37
R-Squared0.02
Alpha-0.22
Financial Highlights & Ratios
Price to Book (P/B)-45.14
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$16.00Price Target Upside384.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
FibroBiologics, Inc. News
Ownership Overview
17.26% Insiders
0.21% Mutual Funds
8.79% Other Institutional Investors
73.75% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FBLG FAQ
What was FibroBiologics, Inc.’s price range in the past 12 months?
FibroBiologics, Inc. lowest stock price was $1.08 and its highest was $55.00 in the past 12 months.
What is FibroBiologics, Inc.’s market cap?
Currently, no data Available
When is FibroBiologics, Inc.’s upcoming earnings report date?
FibroBiologics, Inc.’s upcoming earnings report date is May 14, 2024 which is 130 days ago.
How were FibroBiologics, Inc.’s earnings last quarter?
Currently, no data Available
Is FibroBiologics, Inc. overvalued?
According to Wall Street analysts FibroBiologics, Inc.’s price is currently Undervalued.
Does FibroBiologics, Inc. pay dividends?
FibroBiologics, Inc. does not currently pay dividends.
What is FibroBiologics, Inc.’s EPS estimate?
FibroBiologics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FibroBiologics, Inc. have?
FibroBiologics, Inc. has 35,159,126 shares outstanding.
What happened to FibroBiologics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of FibroBiologics, Inc.?
Among the largest hedge funds holding FibroBiologics, Inc.’s share is Fund Evaluation Group, LLC. It holds FibroBiologics, Inc.’s shares valued at 5M.
---
FibroBiologics, Inc. Stock Smart Score
Company Description
FibroBiologics, Inc.
FibroBiologics, Inc. operates as a clinical-stage cell therapy company that focuses on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs. The company develops CybroCell for degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for treating wound healing. Its early-stage research programs include CYTER915 which is designed to regenerate or reinvigorate production of the thymus and/or spleen; and TCB190 for the treatment of cancers. The company was incorporated in 2021 and is based in Houston, Texas. FibroBiologics, Inc. operates as a subsidiary of Spinalcyte Llc.
---
FBLG Stock 12 Month Forecast
Average Price Target
$16.00
▲(384.85% Upside)
Technical Analysis
Best Analysts Covering FBLG
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+106.50%
initiated a buy rating 17 days ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +106.50% per trade.
---